Cargando…
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study
Emerging data indicate that genomic alterations can shape immune cell composition in early breast cancer. However, there is a need for complementary imaging and sequencing methods for the quantitative assessment of combined somatic copy number alteration (SCNA) and immune profiling in pathological s...
Autores principales: | Zerdes, Ioannis, Simonetti, Michele, Matikas, Alexios, Harbers, Luuk, Acs, Balazs, Boyaci, Ceren, Zhang, Ning, Salgkamis, Dimitrios, Agartz, Susanne, Moreno-Ruiz, Pablo, Bai, Yalai, Rimm, David L., Hartman, Johan, Mezheyeuski, Artur, Bergh, Jonas, Crosetto, Nicola, Foukakis, Theodoros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604966/ https://www.ncbi.nlm.nih.gov/pubmed/34799582 http://dx.doi.org/10.1038/s41523-021-00352-3 |
Ejemplares similares
-
Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution
por: Tzoras, Evangelos, et al.
Publicado: (2022) -
The interplay between eosinophils and T cells in breast cancer immunotherapy
por: Zerdes, Ioannis, et al.
Publicado: (2023) -
Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
por: Chrétien, Sebastian, et al.
Publicado: (2019) -
Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
por: Zerdes, Ioannis, et al.
Publicado: (2021) -
Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis
por: Zhu, Yajing, et al.
Publicado: (2022)